16-57382093-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002996.6(CX3CL1):c.255G>A(p.Ala85=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00203 in 1,613,736 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 38 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 25 hom. )
Consequence
CX3CL1
NM_002996.6 synonymous
NM_002996.6 synonymous
Scores
8
Clinical Significance
Conservation
PhyloP100: -1.17
Genes affected
CX3CL1 (HGNC:10647): (C-X3-C motif chemokine ligand 1) This gene belongs to the CX3C subgroup of chemokines, characterized by the number of amino acids located between the conserved cysteine residues. This is the only member of the CX3C subgroup, which contains three amino acids between cysteine residues, resulting in a Cys-X-X-X-Cys configuration. The encoded protein contains an extended mucin-like stalk with a chemokine domain on top, and exists in both a membrane-anchored form where it acts as a binding molecule, or, in soluble form, as a chemotactic cytokine. The mature form of this protein can be cleaved at the cell surface, yielding different soluble forms that can interact with the G-protein coupled receptor, C-X3-C motif chemokine receptor 1 gene product. This gene plays a role in a wide range of diseases, including cancer, vasculitis, neuropathies, atherosclerosis, inflammatory diseases, and in human immunodeficiency virus infections. [provided by RefSeq, Sep 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003140062).
BP6
Variant 16-57382093-G-A is Benign according to our data. Variant chr16-57382093-G-A is described in ClinVar as [Benign]. Clinvar id is 716483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.17 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0113 (1719/152306) while in subpopulation AFR AF= 0.0393 (1634/41560). AF 95% confidence interval is 0.0377. There are 38 homozygotes in gnomad4. There are 814 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 38 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CX3CL1 | NM_002996.6 | c.255G>A | p.Ala85= | synonymous_variant | 3/3 | ENST00000006053.7 | NP_002987.1 | |
CX3CL1 | NM_001304392.3 | c.-1G>A | 5_prime_UTR_variant | 2/2 | NP_001291321.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CX3CL1 | ENST00000006053.7 | c.255G>A | p.Ala85= | synonymous_variant | 3/3 | 1 | NM_002996.6 | ENSP00000006053 | P4 | |
CX3CL1 | ENST00000565912.1 | c.141G>A | p.Ala47= | synonymous_variant | 2/2 | 1 | ENSP00000464114 | |||
CX3CL1 | ENST00000564948.1 | c.134G>A | p.Arg45Gln | missense_variant | 2/2 | 3 | ENSP00000457996 | |||
CX3CL1 | ENST00000563383.1 | c.273G>A | p.Ala91= | synonymous_variant | 3/3 | 5 | ENSP00000456830 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0112 AC: 1710AN: 152188Hom.: 38 Cov.: 32
GnomAD3 genomes
AF:
AC:
1710
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00263 AC: 659AN: 250880Hom.: 11 AF XY: 0.00181 AC XY: 246AN XY: 135644
GnomAD3 exomes
AF:
AC:
659
AN:
250880
Hom.:
AF XY:
AC XY:
246
AN XY:
135644
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00107 AC: 1557AN: 1461430Hom.: 25 Cov.: 31 AF XY: 0.000931 AC XY: 677AN XY: 726956
GnomAD4 exome
AF:
AC:
1557
AN:
1461430
Hom.:
Cov.:
31
AF XY:
AC XY:
677
AN XY:
726956
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0113 AC: 1719AN: 152306Hom.: 38 Cov.: 32 AF XY: 0.0109 AC XY: 814AN XY: 74468
GnomAD4 genome
AF:
AC:
1719
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
814
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
176
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
409
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
N;N;N;N
PROVEAN
Benign
N
Vest4
MVP
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at